Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model
Charles I. Berul, … , Michael E. Mendelsohn, Sita Reddy
Charles I. Berul, … , Michael E. Mendelsohn, Sita Reddy
Published February 15, 1999
Citation Information: J Clin Invest. 1999;103(4):R1-R7. https://doi.org/10.1172/JCI5346.
View: Text | PDF
Article

DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model

  • Text
  • PDF
Abstract

Myotonic dystrophy (DM) is the most common form of muscular dystrophy and is caused by expansion of a CTG trinucleotide repeat on human chromosome 19. Patients with DM develop atrioventricular conduction disturbances, the principal cardiac manifestation of this disease. The etiology of the pathophysiological changes observed in DM has yet to be resolved. Haploinsufficiency of myotonic dystrophy protein kinase (DMPK), DM locus-associated homeodomain protein (DMAHP) and/or titration of RNA-binding proteins by expanded CUG sequences have been hypothesized to underlie the multi-system defects observed in DM. Using an in vivo murine electrophysiology study, we show that cardiac conduction is exquisitely sensitive to DMPK gene dosage. DMPK–/– mice develop cardiac conduction defects which include first-, second-, and third-degree atrioventricular (A–V) block. Our results demonstrate that the A–V node and the His-Purkinje regions of the conduction system are specifically compromised by DMPK loss. Importantly, DMPK+/– mice develop first-degree heart block, a conduction defect strikingly similar to that observed in DM patients. These results demonstrate that DMPK dosage is a critical element modulating cardiac conduction integrity and conclusively link haploinsufficiency of DMPK with cardiac disease in myotonic dystrophy.

Authors

Charles I. Berul, Colin T. Maguire, Mark J. Aronovitz, Jessica Greenwood, Carol Miller, Josef Gehrmann, David Housman, Michael E. Mendelsohn, Sita Reddy

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Selected examples of ECG and intracardiac electrogram tracings from DMPK...
Selected examples of ECG and intracardiac electrogram tracings from DMPK–/– mice with varying degrees of atrioventricular (A–V) block. (a) First-degree A–V block. The P–R interval on ECG is prolonged to 47 ms, coincident with a long A–V interval on intracardiac recordings from right atrium and ventricle. (b) An example of Mobitz type I second-degree A–V block (Wenckebach phenomenon) in a DMPK–/– mouse, with gradual P–R prolongation on surface ECG and A–V prolongation on intracardiac electrograms on each successive cycle until the atrial impulse is not conducted to the ventricle. (c) An example of third degree A–V block in a DMPK–/– mouse, with complete dissociation of the P waves from the QRS complexes. (d) Representative composite telemetered ECG samples from 3 different mice during unrestrained, unanesthetized ambulation. (a) A control DMPK+/+ mouse has an SCL of 102 ms and a P–R interval of 30 ms on the frontal ECG lead. (b) An example of a telemetered ECG from a DMPK+/– mouse, with an SCL of 112 ms and a P–R interval of 40 ms. (c) A tracing from a DMPK–/– mouse, with an SCL of 115 ms and a P–R interval of 43 ms. IEGM, intracardiac electrogram; RA, right atrium; RV, right ventricle; SCL, sinus cyle length.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts